• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用表观遗传重编程治疗儿科脑癌。

Using Epigenetic Reprogramming to Treat Pediatric Brain Cancer.

机构信息

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

Cancer Cell. 2017 May 8;31(5):609-611. doi: 10.1016/j.ccell.2017.04.008.

DOI:10.1016/j.ccell.2017.04.008
PMID:28486100
Abstract

In this issue of Cancer Cell, Nagaraja et al. dissect the molecular mechanisms underlying therapeutic responses to transcriptional disruptors in the fatal pediatric brain tumor, diffuse intrinsic pontine glioma (DIPG). Moreover, they identify super-enhancers mediating these effects, highlighting how normal brain developmental programs can be hijacked in cancer.

摘要

在本期《癌细胞》杂志中,Nagaraja 等人剖析了导致致命性小儿脑肿瘤——弥漫性内在脑桥胶质瘤(DIPG)对转录干扰治疗产生反应的分子机制。此外,他们还鉴定了介导这些效应的超级增强子,强调了正常大脑发育程序如何在癌症中被劫持。

相似文献

1
Using Epigenetic Reprogramming to Treat Pediatric Brain Cancer.利用表观遗传重编程治疗儿科脑癌。
Cancer Cell. 2017 May 8;31(5):609-611. doi: 10.1016/j.ccell.2017.04.008.
2
Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape.弥漫性脑桥内在型胶质瘤的临床病理学及其重新定义的基因组和表观基因组格局
Cancer Genet. 2015 Jul-Aug;208(7-8):367-73. doi: 10.1016/j.cancergen.2015.04.008. Epub 2015 May 1.
3
Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.脂质体阿霉素对流增强递送治疗小儿弥漫性脑桥内在型胶质瘤和丘脑高级别胶质瘤的临床前评估
J Neurosurg Pediatr. 2017 May;19(5):518-530. doi: 10.3171/2016.9.PEDS16152. Epub 2017 Feb 17.
4
Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma.弥漫性脑桥内在型胶质瘤的表观遗传靶向治疗
Neurol Med Chir (Tokyo). 2017 Jul 15;57(7):331-342. doi: 10.2176/nmc.ra.2017-0018. Epub 2017 Jun 7.
5
Incidental diagnosis of diffuse intrinsic pontine glioma in children.儿童弥漫性脑桥内在型胶质瘤的偶然诊断
Pediatr Blood Cancer. 2015 Jun;62(6):1081-3. doi: 10.1002/pbc.25408. Epub 2015 Jan 16.
6
Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial.儿童弥漫性脑桥内在型胶质瘤(DIPG)的大分割适形放疗:一项随机对照试验
Radiother Oncol. 2014 Apr;111(1):35-40. doi: 10.1016/j.radonc.2014.01.013. Epub 2014 Feb 20.
7
A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.荷兰对弥漫性脑桥内生型胶质瘤患儿的诊断与治疗的二十年回顾。
Expert Rev Anticancer Ther. 2015 Feb;15(2):157-64. doi: 10.1586/14737140.2015.974563. Epub 2014 Nov 29.
8
Conventional and Advanced Imaging of Diffuse Intrinsic Pontine Glioma.弥漫性脑桥内在型胶质瘤的传统与先进成像技术
J Child Neurol. 2016 Oct;31(12):1386-93. doi: 10.1177/0883073816634855. Epub 2016 Apr 12.
9
Bioinformatics analysis of microarray data to reveal the pathogenesis of diffuse intrinsic pontine glioma.生物信息学分析微阵列数据以揭示弥漫性内在脑桥胶质瘤的发病机制。
Biol Res. 2018 Aug 20;51(1):26. doi: 10.1186/s40659-018-0175-6.
10
Interpretation of magnetic resonance images in diffuse intrinsic pontine glioma: a survey of pediatric neurosurgeons.弥漫性脑桥内在型胶质瘤的磁共振成像解读:小儿神经外科医生的一项调查
J Neurosurg Pediatr. 2011 Jul;8(1):97-102. doi: 10.3171/2011.4.PEDS1180.

引用本文的文献

1
Epigenetic reprogramming in cancer: From diagnosis to treatment.癌症中的表观遗传重编程:从诊断到治疗。
Front Cell Dev Biol. 2023 Feb 14;11:1116805. doi: 10.3389/fcell.2023.1116805. eCollection 2023.
2
Modeling the developmental origins of pediatric cancer to improve patient outcomes.建立儿童癌症的发育起源模型,以改善患者的预后。
Dis Model Mech. 2021 Feb 22;14(2):dmm048930. doi: 10.1242/dmm.048930.
3
The Making of Leukemia.白血病的形成。
Int J Mol Sci. 2018 May 17;19(5):1494. doi: 10.3390/ijms19051494.